Clinical Trial Update: A Phase I Study of a Novel Tracer for Positron Emission Tomography "PET" Myocardial Perfusion Imaging "MPI" [Phase 1]

View source ↗

Summary

Phase I study of a novel PET tracer for myocardial perfusion imaging in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Synektik PET MPI tracer

Snippet

Sponsor: Synektik S.A. | Conditions: Coronary Artery Disease | Phase 1 | Status: COMPLETED